Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-11-30 Purchase | 2021-12-02 5:08 pm | VYNE Therapeutics Inc. | VYNE | LEPORE PATRICK G Director | 12,500 | $1.0159 | $12,699 | 62,500 (Direct) | View |
| 2021-08-25 Purchase | 2021-08-26 5:04 pm | VYNE Therapeutics Inc. | VYNE | LEPORE PATRICK G Director | 12,500 | $1.6 | $20,000 | 50,000 (Direct) | View |
| 2021-08-16 Sale | 2021-08-18 7:19 pm | VYNE Therapeutics Inc. | VYNE | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 250,000 | $1.74 | $435,000 | 4,935,057 (Indirect) | View |
| 2021-08-13 Sale | 2021-08-17 4:46 pm | VYNE Therapeutics Inc. | VYNE | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 250,000 | $1.84 | $460,000 | 5,185,057 (Indirect) | View |
| 2021-08-12 Sale | 2021-08-16 6:24 pm | VYNE Therapeutics Inc. | VYNE | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 338,897 | $2.23 | $755,740 | 5,435,057 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-09-30 Tax Withholding | 2022-10-04 5:00 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO | 10,683 | $0.223 | 1,040,270 (Direct) | View |
| 2022-08-10 Option Award | 2022-08-12 5:12 pm | N/A 2032-08-10 | VYNE Therapeutics Inc. | VYNE | Sandoval Elisabeth Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2022-08-10 Option Award | 2022-08-12 5:11 pm | N/A 2032-08-10 | VYNE Therapeutics Inc. | VYNE | LEPORE PATRICK G Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2022-08-10 Option Award | 2022-08-12 5:11 pm | N/A 2032-08-10 | VYNE Therapeutics Inc. | VYNE | Bruno Anthony D Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2022-08-10 Option Award | 2022-08-12 5:10 pm | N/A 2032-08-10 | VYNE Therapeutics Inc. | VYNE | Basta Steven L Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2022-08-10 Option Award | 2022-08-12 5:10 pm | N/A 2032-08-10 | VYNE Therapeutics Inc. | VYNE | BARBARI SHARON Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2022-06-30 Tax Withholding | 2022-07-05 5:01 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CFO | 354 | $0.389 | 173,712 (Direct) | View |
| 2022-06-30 Tax Withholding | 2022-07-05 5:01 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 1,719 | $0.389 | 223,691 (Direct) | View |
| 2022-06-30 Tax Withholding | 2022-07-05 5:00 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 1,813 | $0.389 | 232,770 (Direct) | View |
| 2022-06-30 Tax Withholding | 2022-07-05 5:00 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO | 10,683 | $0.389 | 1,050,953 (Direct) | View |
| 2022-05-31 Option Award | 2022-06-02 4:36 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CFO | 12,510 | $0.3463 | 174,066 (Direct) | View |
| 2022-05-31 Option Award | 2022-06-02 4:35 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO | 11,887 | $0.3463 | 1,061,636 (Direct) | View |
| 2022-03-31 Tax Withholding | 2022-04-04 5:10 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CFO | 773 | $0.65 | 161,556 (Direct) | View |
| 2022-03-31 Tax Withholding | 2022-04-04 5:09 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 3,469 | $0.65 | 225,410 (Direct) | View |
| 2022-03-31 Tax Withholding | 2022-04-04 5:09 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 3,630 | $0.65 | 234,583 (Direct) | View |
| 2022-03-31 Tax Withholding | 2022-04-04 5:08 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO | 23,186 | $0.65 | 1,049,749 (Direct) | View |
| 2022-03-17 Option Award | 2022-03-18 5:10 pm | N/A 2032-03-17 | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CFO | 75,000 | $0 | 237,329 (Direct) | View |
| 2022-03-17 Option Award | 2022-03-18 5:10 pm | N/A 2032-03-17 | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 75,000 | $0 | 303,879 (Direct) | View |
| 2022-03-17 Option Award | 2022-03-18 5:09 pm | N/A 2032-03-17 | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 75,000 | $0 | 313,213 (Direct) | View |
| 2022-03-17 Option Award | 2022-03-18 5:09 pm | N/A 2032-03-17 | VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO | 624,605 | $0 | 1,385,238 (Direct) | View |
| 2021-12-31 Tax Withholding | 2022-01-04 4:40 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Interim CFO | 206 | $1.02 | 87,329 (Direct) | View |
| 2021-12-31 Tax Withholding | 2022-01-04 4:40 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 1,250 | $1.02 | 153,879 (Direct) | View |
| 2021-12-31 Tax Withholding | 2022-01-04 4:40 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 1,484 | $1.02 | 163,213 (Direct) | View |
| 2021-12-31 Tax Withholding | 2022-01-04 4:39 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO | 6,887 | $1.02 | 760,633 (Direct) | View |
| 2021-11-30 Option Award | 2021-12-02 5:08 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Interim CFO | 4,187 | $0.8755 | 87,535 (Direct) | View |
| 2021-11-30 Option Award | 2021-12-02 5:07 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO | 4,705 | $0.8755 | 767,520 (Direct) | View |
| 2021-09-30 Tax Withholding | 2021-10-01 5:12 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Interim CFO | 206 | $1.39 | 83,348 (Direct) | View |
| 2021-09-30 Tax Withholding | 2021-10-01 5:12 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 1,480 | $1.39 | 155,129 (Direct) | View |
| 2021-09-30 Tax Withholding | 2021-10-01 5:11 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 1,484 | $1.39 | 164,697 (Direct) | View |
| 2021-09-30 Tax Withholding | 2021-10-01 5:10 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO | 13,096 | $1.39 | 762,815 (Direct) | View |
| 2021-09-02 Option Award | 2021-09-03 5:35 pm | N/A 2031-09-02 | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Interim CFO | 121,719 | $0 | 144,414 (Direct) | View |
| 2021-09-02 Option Award | 2021-09-03 5:34 pm | N/A 2031-09-02 | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 121,719 | $0 | 217,469 (Direct) | View |
| 2021-09-02 Option Award | 2021-09-03 5:34 pm | N/A 2031-09-02 | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 121,719 | $0 | 227,041 (Direct) | View |
| 2021-09-02 Option Award | 2021-09-03 5:33 pm | N/A 2031-09-02 | VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO | 640,625 | $0 | 1,096,224 (Direct) | View |
| 2021-07-19 Option Award | 2021-07-20 5:06 pm | N/A 2031-07-19 | VYNE Therapeutics Inc. | VYNE | Sandoval Elisabeth Director | 20,500 | $0 | 20,500 (Direct) | View |